Cassava Sciences

SAVA NASDAQ
Overview Stats Financials News

Quarterly Financials

Values in thousands 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Revenue $0 $2,348 $0 $0
Gross Profit -311 1,992 -392 -391
EBITDA -19,623 -22,433 -27,879 -28,777
EBIT -19,934 -22,789 -28,271 -29,168
Net Income 25,043 -20,919 -25,651 -26,376
Net Change In Cash 0 2,348 0 0
Cost of Revenue -19,029
Free Cash Flow -19,127 -22,357 -26,552 -19,918
Cash 124,169 121,136 142,350 168,438
Basic Shares 44,102 42,188 42,002 41,793

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue $0 $-1 $0 $0
Gross Profit -1,530 -1 -534 -346
EBITDA -104,427 -78,719 -32,334 -7,138
EBIT -105,957 -80,020 -32,868 -6,446
Net Income -97,217 -72,472 -31,802 -5,854
Net Change In Cash 0 -1 0 0
Cost of Revenue 139,931 70,425
Free Cash Flow -82,439 -80,226 -52,410 -5,382
Cash 121,136 201,015 233,437 93,506
Basic Shares 41,932 40,202 39,405 26,105

Earnings Calls

Quarter EPS
2024-03-31 $0.58
2023-12-31 -$0.50
2023-09-30 -$0.61
2023-06-30 -$0.63